|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-3-8
|
|
pubmed:abstractText |
Polycystic ovary syndrome (PCOS) is a common endocrine disease that is observed frequently to be related to increased insulin resistance. The use of insulin-sensitizer compounds, such as metformin, permits great improvement of such metabolic abnormality and the restoration of normal ovarian function. Metformin administration reduces insulin resistance and androgen production both from the ovary and adrenal gland.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0951-3590
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
36-43
|
|
pubmed:meshHeading |
pubmed-meshheading:16522532-Adult,
pubmed-meshheading:16522532-Analysis of Variance,
pubmed-meshheading:16522532-Androgens,
pubmed-meshheading:16522532-Female,
pubmed-meshheading:16522532-Glucose Tolerance Test,
pubmed-meshheading:16522532-Gonadotropins, Pituitary,
pubmed-meshheading:16522532-Humans,
pubmed-meshheading:16522532-Hydrocortisone,
pubmed-meshheading:16522532-Hypoglycemic Agents,
pubmed-meshheading:16522532-Insulin Resistance,
pubmed-meshheading:16522532-Linear Models,
pubmed-meshheading:16522532-Metformin,
pubmed-meshheading:16522532-Polycystic Ovary Syndrome,
pubmed-meshheading:16522532-Pregnanolone
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of Modena and Reggio Emilia, Modena, Italy. algen@unimore.it
|
|
pubmed:publicationType |
Journal Article
|
